Minimally Invasive Right Colectomy Anastomosis Study

NCT ID: NCT03650517

Last Updated: 2019-09-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-11-01

Study Completion Date

2021-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Right colectomy (hemicolectomy) involves the removal of the cecum, the ascending colon, the hepatic flexure, the first one-third of the transverse colon, part of the terminal ileum, and the associated regional fat and lymph nodes, and is the accepted treatment for malignant neoplasms of the right colon.

A minimally invasive approach is commonly used for right colectomy, with studies reporting reduced complications, less blood loss, and hospital stay when compared to an open approach.

However, there remains controversy regarding whether robotic assistance is advantageous for this technique and whether an intracorporeal (ICA) or extracorporeal anastomosis (ECA) is best.

MIRCAST is a prospective, observational, international, multi-center, 4-parallel-cohorts study. Sites or surgeons will select a cohort of the study for which they are qualified. Four cohorts will be the subject of study:

1. Robotic Right Colectomy with ICA
2. Robotic Right Colectomy with ECA
3. Laparoscopic Right Colectomy with ICA
4. Laparoscopic Right Colectomy with ECA

All patient assessments will be done according to the sites standard of care. Parameters routinely recorded during right colectomy surgery will be collected prospectively. Enrolled subjects will undergo assessments at the following intervals: pre-operative, operative, discharge, 30 days, 3 months, 1 year and 2 years post-surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

MIRCAST study is an observational, prospective, parallel cohorts, international, multi-center to compare robotic assisted and laparoscopic minimally invasive right colectomy, and intracorporeal anastomosis versus extracorporeal anastomosis.

The research is coordinated by Marcos Gómez Ruiz MD PhD from Hospital Universitario Marqués de Valdecilla in Santander, Spain; the sponsorship is performed by Fundacion Instituto de Investigación Marqués de Valdecilla (IDIVAL). The European Society of Coloproctology (ESCP) endorses MIRCAST Study and will run a quality audit/independent monitoring of the study.

The objectives of study are to compare of the peri-operative complications after robotic assisted and laparoscopic minimally invasive right colectomy with intracorporeal anastomosis versus extracorporeal anastomosis.

To Identify potential benefits of robotic assisted procedures for right colon resections.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Cancer Anastomotic Complication Colectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Robotic Right Colectomy with ICA

Robot-assisted surgery (RAS), allows many types of complex MIS procedures using robotic systems to aid in surgical procedures providing more precision, flexibility and control than is possible with other MIS techniques.

Intracorporeal anastomosis: when the anastomosis is performed inside the abdominal cavity with a laparoscopic or robotic technique. A Pfannenstiel incision will be done exclusively for specimen extraction.

Intracorporeal Anastomosis

Intervention Type PROCEDURE

Anastomosis is performed inside the abdominal cavity with a laparoscopic or robotic technique

Robotic Surgery

Intervention Type PROCEDURE

Procedure is performed using robotic instruments

Robotic Right Colectomy with ECA

Robot-assisted surgery (RAS), allows many types of complex MIS procedures using robotic systems to aid in surgical procedures providing more precision, flexibility and control than is possible with other MIS techniques.

Extracorporeal anastomosis: when the anastomosis is performed by pulling out the bowel through a laparotomy wherever that laparotomy is performed.

Extracorporeal Anastomosis

Intervention Type PROCEDURE

Anastomosis is performed by pulling out the bowel through a laparotomy wherever that laparotomy is performed.

Robotic Surgery

Intervention Type PROCEDURE

Procedure is performed using robotic instruments

Laparoscopic Right Colectomy with ICA

Laparoscopic surgery, also called minimally invasive surgery (MIS), or keyhole surgery, is a surgical technique in which operations are performed far from their location through small incisions (usually 0.5-1.5 cm) elsewhere in the body.

Intracorporeal anastomosis: when the anastomosis is performed inside the abdominal cavity with a laparoscopic or robotic technique. A Pfannenstiel incision will be done exclusively for specimen extraction.

Intracorporeal Anastomosis

Intervention Type PROCEDURE

Anastomosis is performed inside the abdominal cavity with a laparoscopic or robotic technique

Laparoscopic Surgery

Intervention Type PROCEDURE

Procedure is performed using standard laparoscopic instruments

Laparoscopic Right Colectomy with ECA

Laparoscopic surgery, also called minimally invasive surgery (MIS), or keyhole surgery, is a surgical technique in which operations are performed far from their location through small incisions (usually 0.5-1.5 cm) elsewhere in the body.

Extracorporeal anastomosis: when the anastomosis is performed by pulling out the bowel through a laparotomy wherever that laparotomy is performed.

Extracorporeal Anastomosis

Intervention Type PROCEDURE

Anastomosis is performed by pulling out the bowel through a laparotomy wherever that laparotomy is performed.

Laparoscopic Surgery

Intervention Type PROCEDURE

Procedure is performed using standard laparoscopic instruments

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Extracorporeal Anastomosis

Anastomosis is performed by pulling out the bowel through a laparotomy wherever that laparotomy is performed.

Intervention Type PROCEDURE

Intracorporeal Anastomosis

Anastomosis is performed inside the abdominal cavity with a laparoscopic or robotic technique

Intervention Type PROCEDURE

Robotic Surgery

Procedure is performed using robotic instruments

Intervention Type PROCEDURE

Laparoscopic Surgery

Procedure is performed using standard laparoscopic instruments

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years or older.
* Right colon tumor with indication for right colectomy (benign or malignant disease)
* Patient has a life expectancy of at least 12 weeks
* Patients with adequate performance status (Eastern Cooperative Oncology Group Scale score of ≤2)
* Patient has signed and dated the Informed consent before patient inclusion in the study

Exclusion Criteria

* Patient with a comorbid illness or condition that would preclude the use of surgery
* Patients with cT4b tumors
* Patients unwilling to comply with all follow-up study requirements
* Patient undergoing emergency procedures
* Planned colonic surgery along with major concomitant procedures (e.g. liver resections, other intestinal resections)
* Metastatic disease
* Pregnant or suspected pregnancy
* Inflammatory Bowel Disease (Crohn´s Disease or Ulcerative Colitis)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Instituto de Investigación Marqués de Valdecilla

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marcos Gómez Ruiz, MD PhD

Role: PRINCIPAL_INVESTIGATOR

Hospital Universitario Marqués de Valdecilla, IDIVAL

Galo Peralta, MD

Role: STUDY_CHAIR

Instituto de Investigación Marqués de Valdecilla

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

County Hospital Požega

Požega, , Croatia

Site Status RECRUITING

Hospital of Southern Denmark

Aabenraa, , Denmark

Site Status ACTIVE_NOT_RECRUITING

Zealand University Hospital

Køge, , Denmark

Site Status ACTIVE_NOT_RECRUITING

Kanta-Hämeen Keskussairaala

Hämeenlinna, , Finland

Site Status NOT_YET_RECRUITING

Kymenlaakso Central Hospital

Kotka, , Finland

Site Status RECRUITING

Päijät-Häme Central Hospital

Lahti, , Finland

Site Status RECRUITING

Oulu University Hospital

Oulu, , Finland

Site Status RECRUITING

Seinäjoki Central Hospital

Seinäjoki, , Finland

Site Status RECRUITING

Hôpital Haut-Lévèque- CHU

Bordeaux, , France

Site Status ACTIVE_NOT_RECRUITING

CHU Estaing

Clermont-Ferrand, , France

Site Status NOT_YET_RECRUITING

ICM - Institut Régional du Cancer de Montpellier

Montpellier, , France

Site Status RECRUITING

CHRU de Strasbourg Hôpital Civil

Strasbourg, , France

Site Status NOT_YET_RECRUITING

CHRU Nancy Brabois

Vandœuvre-lès-Nancy, , France

Site Status NOT_YET_RECRUITING

Medizinische Hochschule Hannover

Hanover, , Germany

Site Status NOT_YET_RECRUITING

Eurokliniki Athinou

Athens, Athina, Greece

Site Status RECRUITING

AOU-Careggi

Florence, , Italy

Site Status NOT_YET_RECRUITING

Ospedale La Misericordia

Grosseto, , Italy

Site Status RECRUITING

IEO - European Institute of Oncology

Milan, , Italy

Site Status RECRUITING

Policlínico Agostino Gemelli

Roma, , Italy

Site Status RECRUITING

Humanitas Research Hospital

Rozzano, , Italy

Site Status RECRUITING

IRCCS Istituto di Candiolo

Torino, , Italy

Site Status NOT_YET_RECRUITING

Centro Hospitalar de Leiria

Leiria, , Portugal

Site Status NOT_YET_RECRUITING

Hospital General Universitario de Elche

Elche, Alicante, Spain

Site Status RECRUITING

Hospital Universitario Donostia

Donostia / San Sebastian, Basque Country, Spain

Site Status RECRUITING

Hospital Universitario Marqués de Valdecilla

Santander, Cantabria, Spain

Site Status RECRUITING

Hospital Universitario Vall d´hebron

Barcelona, Catalonia, Spain

Site Status RECRUITING

Hospital Central de Asturias

Oviedo, Principality of Asturias, Spain

Site Status RECRUITING

Complejo hospitalario de Torrecardenas

Almería, , Spain

Site Status RECRUITING

Hospital de León

León, , Spain

Site Status RECRUITING

Hospital Clínico San Carlos

Madrid, , Spain

Site Status RECRUITING

Hospital Universitario 12 de octubre

Madrid, , Spain

Site Status RECRUITING

Portsmouth Hospital NHS Trust

Portsmouth, , United Kingdom

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Croatia Denmark Finland France Germany Greece Italy Portugal Spain United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marcos Gómez Ruiz, MD PhD

Role: CONTACT

0034942202520 ext. 73733

Lucía Lavín Alconero, BSc PhD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Arto Turunen

Role: primary

Pälvi Vento

Role: primary

Jyrki Kössi

Role: primary

Tero Rautio

Role: primary

Tarja Pinta

Role: primary

Anne DUBOIS

Role: primary

Philippe ROUANET

Role: primary

Benoit ROMAIN Benoit

Role: primary

Laurent BRESLER

Role: primary

Markus Winny

Role: primary

Thalia Petropoulou

Role: primary

Andrea Coratti

Role: primary

Paolo Pietro Bianchi, MD PhD

Role: primary

Wanda Luisa Petz

Role: primary

Dominico D´Ugo

Role: primary

Antonino Spinelli

Role: primary

Dario RIBERO

Role: primary

Nuno Rama

Role: primary

Antonio Arroyo Sebastián, MD

Role: primary

Marcos Gómez Ruiz, MD

Role: primary

Eloy Espin

Role: primary

Nuria Truan Alonso

Role: primary

Pedro Antonio Sanchez Fuentes, MD

Role: primary

Vicente Simó Fernández

Role: primary

Mauricio García Alonso, MD

Role: primary

Eduardo Rubio Gonzalez

Role: primary

Jim Kahn

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Gomez Ruiz M, Bianchi PP, Chaudhri S, Gerjy R, Gogenur I, Jayne D, Khan JS, Rautio T, Sanchez-Guillen L, Spinoglio G, Ulrich A, Rouanet P. Minimally invasive right colectomy anastomosis study (MIRCAST): protocol for an observational cohort study of surgical complications using four surgical techniques for anastomosis in patients with a right colon tumor. BMC Surg. 2020 Jul 13;20(1):151. doi: 10.1186/s12893-020-00803-x.

Reference Type DERIVED
PMID: 32660467 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IDIVAL CI18/27

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.